Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    November 2024
  1. CHEN Z, Sun W, Fei M, Qian K, et al
    Clinical and Sonographic Differences between RET Fusion-Positive and BRAFV600E in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae803. doi: 10.1210.
    >> Share


  2. Correction to: "Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics".
    J Clin Endocrinol Metab. 2024 Nov 1:dgae756. doi: 10.1210.
    >> Share

    October 2024

  3. Correction to: "Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae717. doi: 10.1210.
    >> Share

    September 2024
  4. XU B, Baine MK, Jungbluth A, Alabkaa A, et al
    Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Sep 26:dgae672. doi: 10.1210.
    >> Share

    August 2024
  5. RAMONE T, Ghirri A, Prete A, Matrone A, et al
    Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance.
    J Clin Endocrinol Metab. 2024 Aug 24:dgae575. doi: 10.1210.
    >> Share

  6. STEGENGA MT, Oudijk L, van Velsen EFS, Peeters RP, et al
    Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.
    J Clin Endocrinol Metab. 2024 Aug 21:dgae581. doi: 10.1210.
    >> Share

  7. CASTELLANOS LE, Zafereo ME, Sturgis EM, Wang JR, et al
    Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine.
    J Clin Endocrinol Metab. 2024 Aug 20:dgae576. doi: 10.1210.
    >> Share

  8. IYER PC, Dadu R, Barque A, Zanelli C, et al
    Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay.
    J Clin Endocrinol Metab. 2024;109:2269-2273.
    >> Share

  9. LI G, Ye Z, Wei T, Zhu J, et al
    Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
    J Clin Endocrinol Metab. 2024;109:2294-2305.
    >> Share

  10. ENDO M, Peng J, Nabhan FA, Brock P, et al
    Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.
    J Clin Endocrinol Metab. 2024;109:2317-2324.
    >> Share

  11. WANG JR, Zafereo ME, Cabanillas ME, Wu CC, et al
    The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae532. doi: 10.1210.
    >> Share

    July 2024
  12. FENG J, Wu C, Shen F, Cai W, et al
    Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis.
    J Clin Endocrinol Metab. 2024 Jul 24:dgae501. doi: 10.1210.
    >> Share

  13. JING R, Wu N, Wu Y, Zhang Q, et al
    Efficacy and safety of multikinase inhibitors for patients with refractory thyroid cancer: Systematic review and network meta-analysis.
    J Clin Endocrinol Metab. 2024 Jul 6:dgae454. doi: 10.1210.
    >> Share


  14. Correction to: "TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma".
    J Clin Endocrinol Metab. 2024 Jul 1:dgae442. doi: 10.1210.
    >> Share

    June 2024
  15. SEHGAL K, Serritella A, Liu M, ONeill A, et al
    A phase I/II trial of sapanisertib in advanced anaplastic and radioiodine refractory differentiated thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Jun 29:dgae443. doi: 10.1210.
    >> Share

    May 2024
  16. CAO H, Shangguan L, Zhu H, Hu C, et al
    Prognostic analysis of 131I efficacy after papillary thyroid carcinoma surgery based on CT radiomics.
    J Clin Endocrinol Metab. 2024 May 27:dgae364. doi: 10.1210.
    >> Share

  17. LI G, Chen W, Jiang K, Huang J, et al
    Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC.
    J Clin Endocrinol Metab. 2024;109:1601-1617.
    >> Share

  18. XIAN K, Xu S, Huang H, Xing C, et al
    Synergy of nodal factors in predicting recurrence after treatment of N1b papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 May 15:dgae329. doi: 10.1210.
    >> Share

  19. ZHANG W, Lin S, Wang Z, Zhang W, et al
    Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targets in Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 May 13:dgae327. doi: 10.1210.
    >> Share

    April 2024
  20. PETROVIC I, LoPresti J, Fatemi S, Gianoukakis A, et al
    Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA).
    J Clin Endocrinol Metab. 2024 Apr 30:dgae286. doi: 10.1210.
    >> Share

  21. SANT VR, Radhachandran A, Ivezic V, Lee DT, et al
    From Bench-to-Bedside: How Artificial Intelligence Is Changing Thyroid Nodule Diagnostics.
    J Clin Endocrinol Metab. 2024 Apr 29:dgae277. doi: 10.1210.
    >> Share

  22. ABOU AZAR S, Tobias J, Applewhite M, Angelos P, et al
    Medullary Thyroid Cancer: Single Institute Experience over Three Decades and Risk Factors for Recurrence.
    J Clin Endocrinol Metab. 2024 Apr 23:dgae279. doi: 10.1210.
    >> Share

  23. CHO YY, Ahn SH, Lee EK, Park YJ, et al
    Malignancy Risk of Follicular Neoplasm (Bethesda IV) With Variable Cutoffs of Tumor Size: A Systemic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2024;109:1383-1392.
    >> Share

  24. TODA S, Hiroshima Y, Iwasaki H, Masudo K, et al
    Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
    J Clin Endocrinol Metab. 2024 Apr 17:dgae271. doi: 10.1210.
    >> Share

  25. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
    TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
    >> Share

  26. LIU CQ, Shen CK, Du YX, Li ZM, et al
    Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae214. doi: 10.1210.
    >> Share

    March 2024
  27. MAROTTA V, Rocco D, Crocco A, Deiana MG, et al
    Survival predictors of radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the real-life.
    J Clin Endocrinol Metab. 2024 Mar 19:dgae181. doi: 10.1210.
    >> Share

  28. CHEN H, Liu Y, Wang F, Sun J, et al
    MeIS: DNA methylation-based immune response signatures for thyroid nodule diagnostics.
    J Clin Endocrinol Metab. 2024 Mar 7:dgae141. doi: 10.1210.
    >> Share

  29. HENSLEY SG, Hu MI, Bassett RL, Ying AK, et al
    Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades.
    J Clin Endocrinol Metab. 2024 Mar 4:dgae133. doi: 10.1210.
    >> Share

    February 2024
  30. JAGANNATH S, Mayilvaganan S
    Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma".
    J Clin Endocrinol Metab. 2024 Feb 29:dgae117. doi: 10.1210.
    >> Share

  31. SARKAR R, Bolel P, Kapoor A, Eliseeva E, et al
    An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers.
    J Clin Endocrinol Metab. 2024 Feb 29:dgae114. doi: 10.1210.
    >> Share

  32. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Response to Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?".
    J Clin Endocrinol Metab. 2024 Feb 28:dgae118. doi: 10.1210.
    >> Share

  33. AHMADI S, Kotwal A, Bikas A, Xiang P, et al
    Outcomes of cytologically indeterminate thyroid nodules managed with Genomic Sequencing Classifier.
    J Clin Endocrinol Metab. 2024 Feb 28:dgae112. doi: 10.1210.
    >> Share

  34. VAN DER TUIN K, Ruano D, Knijnenburg J, van der Luijt RB, et al
    Clinically-relevant Germline Variants in Children with Non-Medullary Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Feb 28:dgae107. doi: 10.1210.
    >> Share

  35. MAINO F, Botte M, Dalmiglio C, Valerio L, et al
    Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
    J Clin Endocrinol Metab. 2024;109:722-729.
    >> Share

  36. STEGENGA MT, van Velsen EFS, Oudijk L, Verburg FA, et al
    Clinical and Histopathological Risk Factors for Radioactive Iodine Refractory Follicular and Oncocytic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2024 Feb 13:dgae084. doi: 10.1210.
    >> Share

  37. ALTSHULER B, Bikas A, Pappa T, Marqusee E, et al
    Non-Operative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.
    J Clin Endocrinol Metab. 2024 Feb 13:dgae082. doi: 10.1210.
    >> Share

    January 2024
  38. CONDELLO V, Poma AM, Macerola E, Vignali P, et al
    Prevalence, Molecular Landscape and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.
    J Clin Endocrinol Metab. 2024 Jan 22:dgae034. doi: 10.1210.
    >> Share

  39. BHARADWAJ MS, Ballal S, Bal C
    Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.
    J Clin Endocrinol Metab. 2024 Jan 12:dgae024. doi: 10.1210.
    >> Share

  40. BUCZYNSKA A, Kosciuszko M, Sidorkiewicz I, Wiatr AA, et al
    Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer via a Biomarker Panel Involving TAC, 8-OHdG and Sortilin.
    J Clin Endocrinol Metab. 2024 Jan 5:dgae007. doi: 10.1210.
    >> Share

    December 2023
  41. KIM BH, Ryu SR, Lee JW, Song CM, et al
    Longitudinal changes in quality of life before and after thyroidectomy in patients with differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2023 Dec 23:dgad748. doi: 10.1210.
    >> Share

  42. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
    Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
    J Clin Endocrinol Metab. 2023;109:e347-e355.
    >> Share

  43. GOLDNER W
    The Role of Age in the Risk Assessment of Differentiated Thyroid Cancers.
    J Clin Endocrinol Metab. 2023 Dec 20:dgad743. doi: 10.1210.
    >> Share

  44. LIN S, Wang Z, Xing M
    Association between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
    J Clin Endocrinol Metab. 2023 Dec 8:dgad722. doi: 10.1210.
    >> Share

  45. MU Z, Zhang X, Sun D, Sun Y, et al
    Characterizing genetic alterations related to radioiodine avidity in metastatic thyroid cancer.
    J Clin Endocrinol Metab. 2023 Dec 7:dgad697. doi: 10.1210.
    >> Share

  46. LEUNG AM, Brent GA
    Pregnancy - Does Promotion of Growth Extend to Thyroid Cancer?
    J Clin Endocrinol Metab. 2023 Dec 2:dgad707. doi: 10.1210.
    >> Share

  47. WANG Y, Zou B, Zhang Y, Zhang J, et al
    Comprehensive long-read sequencing analysis discloses the transcriptome features of Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Dec 1:dgad695. doi: 10.1210.
    >> Share

    November 2023
  48. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Role of the degree of vascular invasion in predicting prognosis of follicular thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Nov 25:dgad689. doi: 10.1210.
    >> Share

  49. TORA R, Welch J, Sun J, Agarwal SK, et al
    Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    J Clin Endocrinol Metab. 2023;108:3165-3177.
    >> Share

  50. LIU Q, Mao L, Zhang Z, Li G, et al
    Diagnostic Efficacy of FNA-Tg in DTC Cervical LN Metastasis and its Impact Factors: A Large Retrospective Study.
    J Clin Endocrinol Metab. 2023;108:3311-3319.
    >> Share

  51. FALCHETTI A
    New Perspective on the Genetic Dissection Underlying the Development of Parathyroid Cancer.
    J Clin Endocrinol Metab. 2023;108:e1751-e1752.
    >> Share

  52. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    >> Share

    October 2023
  53. KWON H, Han KD, Moon SJ, Park SE, et al
    Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
    >> Share

  54. DAI P, Zhao W, Zheng X, Luo H, et al
    Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant.
    J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
    >> Share


  55. Correction to "The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation".
    J Clin Endocrinol Metab. 2023 Oct 3:dgad573. doi: 10.1210.
    >> Share

    September 2023
  56. PALYGA I, Rumian M, Kosel A, Albrzykowski M, et al
    The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy.
    J Clin Endocrinol Metab. 2023 Sep 28:dgad571. doi: 10.1210.
    >> Share

  57. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    >> Share

  58. POZDEYEV N, Dighe M, Barrio M, Raeburn C, et al
    Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant.
    J Clin Endocrinol Metab. 2023 Sep 8:dgad530. doi: 10.1210.
    >> Share

  59. ILGAN S, Aydogan BI, Emer O, Anil C, et al
    Sonographic features of atypical and initially missed parathyroid adenomas: Lessons learned from a single center cohort.
    J Clin Endocrinol Metab. 2023 Sep 5:dgad527. doi: 10.1210.
    >> Share

    August 2023
  60. GILLIS A, Chen H, Wang TS, Dream S, et al
    Racial and Ethnic Disparities in the Diagnosis and Treatment of Thyroid Disease: a Mini- Review.
    J Clin Endocrinol Metab. 2023 Aug 30:dgad519. doi: 10.1210.
    >> Share

  61. HA EJ, Lee JH, Lee DH, Moon J, et al
    Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad503. doi: 10.1210.
    >> Share

  62. JU G, Sun Y, Wang H, Zhang X, et al
    Fusion oncogenes in patients with locally advanced or distant metastatic differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad500. doi: 10.1210.
    >> Share

  63. MACHENS A, Lorenz K, Brandenburg T, Fuhrer-Sakel D, et al
    The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine.
    J Clin Endocrinol Metab. 2023;108:e734-e742.
    >> Share

  64. LI H, Han R, Meng L, Sun Y, et al
    Nodal Metastases Associated with Fusion Oncogenes Are Age Dependent in Young Adult Patients with Thyroid Cancer.
    J Clin Endocrinol Metab. 2023 Aug 3:dgad458. doi: 10.1210.
    >> Share

  65. CETANI F, Pardi E, Torregrossa L, Borsari S, et al
    Approach to the Patient With Parathyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Aug 2:dgad455. doi: 10.1210.
    >> Share

    July 2023
  66. WANG JR, Zafereo ME, Wang W, Joshu C, et al
    Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad407. doi: 10.1210.
    >> Share

  67. MERCADO M
    The Role of Androgen Receptors in Thyroid Cancer Biology: Beyond Sexual Dimorphism.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad424. doi: 10.1210.
    >> Share

  68. TIAN T, Qi Z, Huang S, Wang H, et al
    Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
    J Clin Endocrinol Metab. 2023;108:2033-2041.
    >> Share

  69. NOEL JE, Sinclair CF
    Radiofrequency Ablation for Benign Thyroid Nodules.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad357. doi: 10.1210.
    >> Share

    June 2023
  70. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
    J Clin Endocrinol Metab. 2023 Jun 23:dgad369. doi: 10.1210.
    >> Share

  71. SHAHA AR
    Aggressive Subtypes of Papillary Microcarcinoma.
    J Clin Endocrinol Metab. 2023;108:e489-e490.
    >> Share

  72. XIANG P, Ahmadi S, Coleman A, West W, et al
    Identifying and Predicting Diverse Patterns of Benign Nodule Growth.
    J Clin Endocrinol Metab. 2023;108:e458-e463.
    >> Share

  73. TAO X, Xu T, Lin X, Xu S, et al
    Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    J Clin Endocrinol Metab. 2023;108:1768-1775.
    >> Share

  74. YAN L, Zhen Y, Li Y, Li X, et al
    Five-year Outcome Between Radiofrequency Ablation vs. Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad360. doi: 10.1210.
    >> Share

  75. YEH MW
    The molecular landscape of thyroid nodules: Diagnostic and prognostic revelations from a large multicenter cohort.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad362. doi: 10.1210.
    >> Share

  76. SATAPATHY S, Majeed AK, Ballal S, Bal C, et al
    Differentiated thyroid cancers in young adults versus children: Clinical characteristics and ten-year follow-up outcomes.
    J Clin Endocrinol Metab. 2023 Jun 7:dgad343. doi: 10.1210.
    >> Share

  77. SGRO D, Brancatella A, Greco G, Torregrossa L, et al
    Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad313. doi: 10.1210.
    >> Share

  78. ZHOU Y, Wang Y, Zhang Z, Yin X, et al
    Male sex is not a risk factor for prognosis in postoperative thyroid cancer patients: a propensity score matching study.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad314. doi: 10.1210.
    >> Share

  79. BOJARSKY M, Baran JA, Halada S, Isaza A, et al
    Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad322. doi: 10.1210.
    >> Share

    May 2023
  80. LIN Y, Wu ZR, Shi YP, Ding M, et al
    Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
    J Clin Endocrinol Metab. 2023 May 23:dgad269. doi: 10.1210.
    >> Share

  81. CHOU CK, Chi SY, Hung YY, Yang YC, et al
    Clinical impact of androgen receptor-suppressing miR-146b expression in papillary thyroid cancer aggressiveness.
    J Clin Endocrinol Metab. 2023 May 23:dgad279. doi: 10.1210.
    >> Share

  82. ALZAHRANI AS
    Clinical use of molecular data in thyroid nodules and cancer.
    J Clin Endocrinol Metab. 2023 May 18:dgad282. doi: 10.1210.
    >> Share

  83. NASR CE, Andrioli M, Endo M, Harrell RM, et al
    Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.
    J Clin Endocrinol Metab. 2023;108:1526-1532.
    >> Share

  84. SUN Y, Sun Q, Tian J, He X, et al
    Impact of waiting time for radioactive iodine therapy on outcome in N1 stage papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 May 11:dgad264. doi: 10.1210.
    >> Share

    April 2023
  85. ULLMANN TM, Sosa JA
    Delay in Surgery for Papillary Thyroid Cancer: A Proxy for Lower-Quality Care?
    J Clin Endocrinol Metab. 2023 Apr 21:dgad232. doi: 10.1210.
    >> Share

  86. CHIOSEA S, Hodak SP, Yip L, Abraham D, et al
    Molecular Profiling of 50,734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
    J Clin Endocrinol Metab. 2023 Apr 18:dgad220. doi: 10.1210.
    >> Share

    March 2023
  87. ALSWAILEM M, Alghamdi B, Alotaibi A, Aljomiah A, et al
    Molecular genetics of diffuse sclerosing papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad185. doi: 10.1210.
    >> Share

  88. KIM NE, Raghunathan RS, Hughes EG, Longstaff XR, et al
    Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210.
    >> Share

  89. ALZAHRANI AS
    The risk of expanding risk stratification in thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad182. doi: 10.1210.
    >> Share

  90. CHAVES N, Broekhuis JM, Fligor SC, Collins RA, et al
    Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: a SEER-Medicare Analysis.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad163. doi: 10.1210.
    >> Share

  91. VAN VELSEN EFS, Verburg FA
    Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad171. doi: 10.1210.
    >> Share

  92. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
    Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad173. doi: 10.1210.
    >> Share

  93. NASR CE
    Can one predict long-term growth of cytologically-benign thyroid nodules?
    J Clin Endocrinol Metab. 2023 Mar 22:dgad160. doi: 10.1210.
    >> Share

  94. JHA S, Welch J, Tora R, Lack J, et al
    Germline and somatic inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors.
    J Clin Endocrinol Metab. 2023 Mar 20:dgad136. doi: 10.1210.
    >> Share

    February 2023
  95. GRANI G, Del Gatto V, Cantisani V, Mandel SJ, et al
    A reappraisal of suspicious sonographic features of thyroid nodules: shape is not an independent predictor of malignancy.
    J Clin Endocrinol Metab. 2023 Feb 22:dgad092. doi: 10.1210.
    >> Share

  96. GRANI G, Gentili M, Siciliano F, Albano D, et al
    A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study.
    J Clin Endocrinol Metab. 2023 Feb 16:dgad075. doi: 10.1210.
    >> Share

  97. SEISA MO, Nayfeh T, Hasan B, Firwana M, et al
    A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults.
    J Clin Endocrinol Metab. 2023;108:585-591.
    >> Share

  98. PRETE A, Gambale C, Torregrossa L, Ciampi R, et al
    Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment.
    J Clin Endocrinol Metab. 2023 Feb 1:dgad061. doi: 10.1210.
    >> Share

    January 2023
  99. PRAW SS, Brent GA
    Approach to the Patient With a Suppressed TSH.
    J Clin Endocrinol Metab. 2023;108:472-482.
    >> Share

  100. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Response to Letter to the Editor from Yang et al.: "Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    J Clin Endocrinol Metab. 2023 Jan 6:dgac754. doi: 10.1210.
    >> Share

  101. YANG S, Tan M, Gao F, Xu X, et al
    Letter to the Editor from Yang et al.: "Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    J Clin Endocrinol Metab. 2023 Jan 2:dgac753. doi: 10.1210.
    >> Share

    December 2022
  102. MAJEED AK, Satapathy S, Ballal S, Bal C, et al
    Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Dec 29:dgac731. doi: 10.1210.
    >> Share

  103. ZHANG X, Liu JR, Mu ZZ, Cheng XQ, et al
    Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-risk Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2022 Dec 26:dgac745. doi: 10.1210.
    >> Share

  104. LEE JS, Lee JS, Yun HJ, Kim SM, et al
    Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm.
    J Clin Endocrinol Metab. 2022 Dec 21:dgac739. doi: 10.1210.
    >> Share

  105. RANA C, Bychkov A
    NIFTP Statistics-Now You See It, Now You Don't.
    J Clin Endocrinol Metab. 2022;108:e5-e6.
    >> Share

  106. VAN VELSEN EFS, Peeters RP, Stegenga MT, van Kemenade FJ, et al
    Evaluating Disease Specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2022 Dec 12:dgac721. doi: 10.1210.
    >> Share

    November 2022
  107. PEREZ MN, Halada S, Isaza A, Sisko L, et al
    Health-Related Quality of Life at Diagnosis for Pediatric Thyroid Cancer Patients.
    J Clin Endocrinol Metab. 2022 Nov 4. pii: 6795528. doi: 10.1210.
    >> Share

  108. ULLMANN TM, Papaleontiou M, Sosa JA
    Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.
    J Clin Endocrinol Metab. 2022 Nov 3. pii: 6795262. doi: 10.1210.
    >> Share

  109. BROEKHUIS JM, James BC
    Delays in Surgery for Differentiated Thyroid Carcinomas: How Long is Reasonable, and What Questions Remain?
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785940. doi: 10.1210.
    >> Share

    October 2022
  110. TIAN T, Huang S, Dai H, Qi M, et al
    Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid Cancer in Child, Adolescent, and Young Adult.
    J Clin Endocrinol Metab. 2022 Oct 13. pii: 6760001. doi: 10.1210.
    >> Share

  111. RIVKEES SA
    Approach to the Patient: Management and the Long-Term Consequences of Graves' Disease in Children.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6746564. doi: 10.1210.
    >> Share

  112. MA B, Wen S, Luo Y, Zhang T, et al
    Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6747527. doi: 10.1210.
    >> Share

    September 2022
  113. ANGELL TE, Kwon DI
    Finding the Balance on Extent of Initial Thyroidectomy for Low-Risk Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Sep 22. pii: 6711571. doi: 10.1210.
    >> Share

  114. PALERMO A, Sodo A, Naciu AM, Gioacchino MD, et al
    Clinical use of Raman spectroscopy improves diagnostic accuracy for indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6697971. doi: 10.1210.
    >> Share

  115. PALERMO A, Cesareo R
    Response to Letter to the Editor from Xu and Yang: Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules:12-Month Results of a Randomized Trial (LARA II Study).
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691130. doi: 10.1210.
    >> Share

  116. ZHOU H, Wu J, Shi L, Wang Y, et al
    Analysis of delayed surgery and clinical outcomes in intermediate- and high-risk papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691129. doi: 10.1210.
    >> Share

    August 2022
  117. MA X, Ma X, Chin L, Zhu Z, et al
    A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
    J Clin Endocrinol Metab. 2022;107:2636-2643.
    >> Share

  118. ARROYO N, Bell KJL, Hsiao V, Fernandes-Taylor S, et al
    Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.
    J Clin Endocrinol Metab. 2022 Aug 10. pii: 6659928. doi: 10.1210.
    >> Share

  119. CHEN DW, Rob FI, Mukherjee R, Giordano TJ, et al
    Variation in the diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    J Clin Endocrinol Metab. 2022 Aug 3. pii: 6653515. doi: 10.1210.
    >> Share

  120. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Prevalence of Postoperatively-Detected High-Risk Features in 2-4cm Papillary Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Aug 1. pii: 6653085. doi: 10.1210.
    >> Share

    July 2022
  121. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy does not improve cancer-specific survival in Hurthle cell carcinoma of the thyroid.
    J Clin Endocrinol Metab. 2022 Jul 31. pii: 6652584. doi: 10.1210.
    >> Share

  122. OMIDAKHSH N, Heck JE, Cockburn M, Ling C, et al
    Thyroid Cancer and Pesticide Use in a Central California Agricultural Area: A Case Control Study.
    J Clin Endocrinol Metab. 2022 Jul 26. pii: 6650257. doi: 10.1210.
    >> Share


  123. Correction to: Lenvatinib Targets PDGFR-beta Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
    J Clin Endocrinol Metab. 2022 Jul 8. pii: 6633918. doi: 10.1210.
    >> Share

    June 2022
  124. ALZAHRANI AS, Alswailem M, Alghamdi B, Al-Hindi H, et al
    Fumarate hydratase is a novel gene for familial non-medullary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 25. pii: 6618018. doi: 10.1210.
    >> Share

  125. WANG K, Liu S, Tian Y, Liu C, et al
    PDZK1 interacting protein 1 (PDZK1IP1) promotes the progression of papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 21. pii: 6612492. doi: 10.1210.
    >> Share

  126. SAVVATEEVA M, Kudryavtseva A, Lukyanova E, Kobelyatskaya A, et al
    Somatic Mutation Profiling in Head and Neck Paragangliomas.
    J Clin Endocrinol Metab. 2022;107:1833-1842.
    >> Share

  127. TSANG V, Gill A, Gild M, Lurie B, et al
    Selpercatinib treatment of RET mutated thyroid cancers is associated with gastrointestinal adverse effects.
    J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596759. doi: 10.1210.
    >> Share

    May 2022
  128. ELISEI R, Ciampi R, Matrone A, Prete A, et al
    Somatic Ret Indels In Sporadic Medullary Thyroid Cancer: Prevalence And Response To Selpercatinib.
    J Clin Endocrinol Metab. 2022 May 25. pii: 6591888. doi: 10.1210.
    >> Share

  129. GLASGOW C, Lau EYC, Aloj L, Harper I, et al
    An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    J Clin Endocrinol Metab. 2022;107:1706-1713.
    >> Share

  130. VIOLA D, Poma AM, Elisei R, Basolo F, et al
    Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2653-e2654.
    >> Share

  131. GREEN M, Gosmanov AR
    Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should Not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2647-e2648.
    >> Share

  132. SOE MH, Chiang JM, Flavell RR, Khanafshar E, et al
    Non-iodine Avid Disease is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer with Papillary Histology.
    J Clin Endocrinol Metab. 2022 May 12. pii: 6584960. doi: 10.1210.
    >> Share

  133. BURGOS N, Zhao J, Brito JP, Hoang JK, et al
    Clinician agreement on the classification of thyroid nodules ultrasound features: A survey of two endocrine societies.
    J Clin Endocrinol Metab. 2022 May 6. pii: 6581574. doi: 10.1210.
    >> Share

    April 2022
  134. CIAMPI R, Romei C, Ramone T, Matrone A, et al
    Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Apr 26. pii: 6574259. doi: 10.1210.
    >> Share

  135. VINCZE S, Peters NV, Kuo CL, Brown TC, et al
    GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2022;107:e2021-e2026.
    >> Share

  136. PAPPA T, Ahmadi S, Bikas A, Hwang S, et al
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab. 2022 Apr 19. pii: 6570820. doi: 10.1210.
    >> Share

  137. PAPARODIS RD, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Large, slowly growing, benign thyroid nodules frequently coexist with synchronous thyroid cancers.
    J Clin Endocrinol Metab. 2022 Apr 18. pii: 6570003. doi: 10.1210.
    >> Share

  138. ULLMANN TM, Duh QY
    Isolated Lateral Neck Nodal Metastases in Patients with Papillary Thyroid Cancer: Does Cervical Compartment Matter?
    J Clin Endocrinol Metab. 2022 Apr 12. pii: 6567539. doi: 10.1210.
    >> Share

  139. HUANG L, Feng X, Yang W, Li X, et al
    Appraising the effect of potential risk factors on thyroid cancer: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Apr 2. pii: 6562772. doi: 10.1210.
    >> Share

    March 2022
  140. ZHAO ZL, Wei Y, Peng LL, Li Y, et al
    Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules - Risk Factors and Cause Analysis.
    J Clin Endocrinol Metab. 2022 Mar 21. pii: 6551221. doi: 10.1210.
    >> Share

  141. BOUCAI L, Tuttle RM
    Letter to the Editor from Boucai, L and Tuttle, RM: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545312. doi: 10.1210.
    >> Share

  142. XING M
    Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545262. doi: 10.1210.
    >> Share

    February 2022
  143. WENG HY, Yan T, Qiu WW, Fan YB, et al
    The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537119. doi: 10.1210.
    >> Share

    January 2022
  144. ALEXANDER EK
    Novel Genomic Roadmaps and Their Clinical Translation Ahead.
    J Clin Endocrinol Metab. 2022;107:e886-e887.
    >> Share

  145. HAY ID, Lee RA, Charboneau JW
    Efficacy of ethanol ablation in long-term local control of neck nodal metastases in adult papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2022 Jan 14. pii: 6507732. doi: 10.1210.
    >> Share

  146. JANKOVIC MILJUS J, Guillen-Sacoto MA, Makiadi-Alvarado J, Wert-Lamas L, et al
    Circulating MicroRNA Profiles as Potential Biomarkers for differentiated thyroid cancer recurrence.
    J Clin Endocrinol Metab. 2022 Jan 11. pii: 6503735. doi: 10.1210.
    >> Share

    December 2021
  147. STAN MN, Papaleontiou M, Schmitz JJ, Castro MR, et al
    Non-surgical management of thyroid nodules - the role of ablative therapies.
    J Clin Endocrinol Metab. 2021 Dec 25. pii: 6483061. doi: 10.1210.
    >> Share

  148. ROTONDI M, Chiovato L
    Pre-existing or concomitant thyroiditis in papillary thyroid cancer: Something more than a mere issue of timing?
    J Clin Endocrinol Metab. 2021 Dec 20. pii: 6470727. doi: 10.1210.
    >> Share

  149. FRICH PS, Sigstad E, Berstad AE, Holgersen KF, et al
    Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Dec 18. pii: 6469671. doi: 10.1210.
    >> Share

  150. ASAMOAH EO, Caraballo G, Castro MR
    Identifying and addressing Health disparities in Thyroid Cancer Care.
    J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454343. doi: 10.1210.
    >> Share

    November 2021
  151. BOUCAI L, Seshan V, Williams M, Knauf JA, et al
    Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
    J Clin Endocrinol Metab. 2021 Nov 23. pii: 6433608. doi: 10.1210.
    >> Share

  152. NIETO HR, Thornton CEM, Brookes K, de Menezes AN, et al
    Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.
    J Clin Endocrinol Metab. 2021 Nov 16. pii: 6429719. doi: 10.1210.
    >> Share

  153. WEI Y, Zhao ZL, Wu J, Peng LL, et al
    Response to Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427797. doi: 10.1210.
    >> Share

  154. YANG S, Xu X
    Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427798. doi: 10.1210.
    >> Share

  155. LI H, Zhou X, Wang G, Hua D, et al
    CAR-T cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Nov 9. pii: 6423845. doi: 10.1210.
    >> Share

    October 2021
  156. ROH E, Noh E, Hwang SY, Kim JA, et al
    Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: A nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Oct 28. pii: 6413717. doi: 10.1210.
    >> Share

  157. RADHAKRISHNAN A, Reyes-Gastelum D, Abrahamse P, Gay B, et al
    Physician specialties involved in thyroid cancer diagnosis and treatment: Implications for improving healthcare disparities.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6411790. doi: 10.1210.
    >> Share

  158. KOH J, Zhang R, Roman S, Duh QY, et al
    Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
    J Clin Endocrinol Metab. 2021;106:3168-3183.
    >> Share

  159. SAPONARO F, Pardi E, Mazoni L, Borsari S, et al
    Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
    J Clin Endocrinol Metab. 2021;106:e4565-e4579.
    >> Share

  160. NILUBOL N
    "Cutting the Support" to improve treatment efficacy in thyroid cancer by targeting tumor microenvironment.
    J Clin Endocrinol Metab. 2021 Oct 20. pii: 6406379. doi: 10.1210.
    >> Share

  161. BROSE MS, Panaseykin Y, Konda B, de La Fouchardiere C, et al
    A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Oct 19. pii: 6401965. doi: 10.1210.
    >> Share

  162. CHANDER NR, Chidambaram S, Van Den Heede K, DiMarco AN, et al
    Correlation of pre-operative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6395413. doi: 10.1210.
    >> Share

  163. GOLDFARB M, Christison-Lagay E, Rastatter J, Wasserman J, et al
    "Young children are not the same as adolescents when it comes to treating thyroid cancer".
    J Clin Endocrinol Metab. 2021 Oct 5. pii: 6381652. doi: 10.1210.
    >> Share

    September 2021
  164. SINGH P, Bhadada SK, Dahiya D, Saikia UN, et al
    GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    J Clin Endocrinol Metab. 2021;106:e4084-e4096.
    >> Share

  165. POMA AM, Viola D, Macerola E, Proietti A, et al
    Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
    J Clin Endocrinol Metab. 2021;106:e4109-e4117.
    >> Share

  166. LIN S, Zhu Y, Ji C, Yu W, et al
    METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375332. doi: 10.1210.
    >> Share

  167. KIM BW
    Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
    J Clin Endocrinol Metab. 2021 Sep 23. pii: 6374549. doi: 10.1210.
    >> Share

  168. DEKKER BL, Links MH, Muller Kobold AC, Swart-Busscher LG, et al
    Low iodine diet of four days is sufficient preparation for 131I therapy in differentiated thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Sep 17. pii: 6371836. doi: 10.1210.
    >> Share

    August 2021
  169. SINGH P, Bhadada SK, Arya AK, Saikia UN, et al
    Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis.
    J Clin Endocrinol Metab. 2021 Aug 28. pii: 6358989. doi: 10.1210.
    >> Share

  170. REDLICH A, Luster M, Lorenz K, Lessel L, et al
    Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Aug 20. pii: 6355728. doi: 10.1210.
    >> Share

  171. GIOVANELLA L, Garo ML, Ceriani L, Paone G, et al
    Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 12. pii: 6348893. doi: 10.1210.
    >> Share

  172. HAYES AR, Crawford A, Al Riyami K, Tang C, et al
    Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
    J Clin Endocrinol Metab. 2021 Aug 11. pii: 6348246. doi: 10.1210.
    >> Share

  173. LEE EK, Ahn HY, Ku EJ, Yoo WS, et al
    Cardiovascular outcomes in thyroid cancer patients treated with thyroidectomy: A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 4. pii: 6339941. doi: 10.1210.
    >> Share

    July 2021
  174. CIAPPUCCINI R, Saguet-Rysanek V, Giffard F, Licaj I, et al
    PSMA expression in differentiated thyroid cancer: association with radioiodine, 18FDG uptake, and patient outcome.
    J Clin Endocrinol Metab. 2021 Jul 31. pii: 6332894. doi: 10.1210.
    >> Share

  175. IESATO A, Li S, Roti G, Hacker MR, et al
    Lenvatinib targets PDGFR-beta pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327813. doi: 10.1210.
    >> Share

  176. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    >> Share

  177. TAO Y, Wang F, Shen X, Zhu G, et al
    BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 17. pii: 6323355. doi: 10.1210.
    >> Share

  178. GIANI C, Torregrossa L, Ramone T, Romei C, et al
    Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 3. pii: 6291802. doi: 10.1210.
    >> Share

  179. YANG S, Xu X
    Letter to the Editor from [Xiequn Xu]: (Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study)).
    J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312741. doi: 10.1210.
    >> Share

    June 2021
  180. PAULSSON JO, Rafati N, DiLorenzo S, Chen Y, et al
    Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in microRNA processing subunit DGCR8.
    J Clin Endocrinol Metab. 2021 Jun 25. pii: 6309631. doi: 10.1210.
    >> Share

  181. RADEBE L, van der Kaay DCM, Wasserman JD, Goldenberg A, et al
    Predicting Malignancy with Pediatric Thyroid Nodules: Early Experience in Machine Learning for Clinical Decision Support.
    J Clin Endocrinol Metab. 2021 Jun 23. pii: 6308313. doi: 10.1210.
    >> Share

  182. MANIAKAS A, Henderson YC, Hei H, Peng S, et al
    Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity.
    J Clin Endocrinol Metab. 2021 Jun 19. pii: 6306517. doi: 10.1210.
    >> Share

  183. TIAN T, Xu Y, Zhang X, Liu B, et al
    Prognostic implications of pre-ablation stimulated Tg: a retrospective analysis of 2500 thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Jun 18. pii: 6304758. doi: 10.1210.
    >> Share

  184. LIMBACH AL, Sipos JA
    Indeterminate thyroid nodules: the hazy genomic landscape coming into focus.
    J Clin Endocrinol Metab. 2021 Jun 16. pii: 6303548. doi: 10.1210.
    >> Share

  185. HENDERSON YC, Mohamed ASR, Maniakas A, Chen Y, et al
    A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Jun 12. pii: 6297567. doi: 10.1210.
    >> Share

    May 2021
  186. HU MI, Waguespack SG, Dosiou C, Ladenson PW, et al
    Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 May 19. pii: 6278308. doi: 10.1210.
    >> Share

  187. SUTEAU V, Seegers V, Munier M, Ben Boubaker R, et al
    G Protein-Coupled Receptors in radioiodine-refractory thyroid cancer in the Era of Precision Medicine.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6277036. doi: 10.1210.
    >> Share

  188. PITT SC, Haymart MR
    Breaking Down or Waking Up? Psychological Distress and Sleep Disturbance in Patients with Thyroid Nodules and Cancer.
    J Clin Endocrinol Metab. 2021 May 13. pii: 6274981. doi: 10.1210.
    >> Share

  189. RAUE F, Bruckner T, Frank-Raue K
    Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma.
    J Clin Endocrinol Metab. 2021 May 11. pii: 6273583. doi: 10.1210.
    >> Share

    April 2021
  190. VALERIO L, Guidoccio F, Giani C, Tardelli E, et al
    [ 18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patients' survival.
    J Clin Endocrinol Metab. 2021 Apr 26. pii: 6253809. doi: 10.1210.
    >> Share

  191. LI R, Li G, Wang Y, Bao T, et al
    Psychological distress and sleep disturbance throughout thyroid nodules screening, diagnosis and treatment.
    J Clin Endocrinol Metab. 2021 Apr 8. pii: 6217326. doi: 10.1210.
    >> Share

    March 2021
  192. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Exceptionality of Distant Metastases in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    J Clin Endocrinol Metab. 2021 Mar 31. pii: 6206751. doi: 10.1210.
    >> Share

  193. CHERELLA CE, Richman DM, Liu E, Frates MC, et al
    Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Mar 29. pii: 6199870. doi: 10.1210.
    >> Share

  194. LIN YS, Zhang X, Wang C, Liu YQ, et al
    Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 26. pii: 6189101. doi: 10.1210.
    >> Share

  195. SEO GH, Ae Kong K, Kim BS, Seo YK, et al
    Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-Based Study.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6184125. doi: 10.1210.
    >> Share

  196. WALLNER LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al
    Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 4. pii: 6158968. doi: 10.1210.
    >> Share

  197. XI C, Zhang Q, Song HJ, Shen CT, et al
    Pregnancy does not affect the Prognoses of Differentiated Thyroid Cancer Patients with Lung Metastases.
    J Clin Endocrinol Metab. 2021 Mar 1. pii: 6155712. doi: 10.1210.
    >> Share

    February 2021
  198. CHEN DW, Reyes-Gastelum D, Hawley ST, Wallner LP, et al
    Unmet Information Needs Among Hispanic Women with Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154483. doi: 10.1210.
    >> Share

  199. LI CW, Shi X, Ma B, Wang YL, et al
    A Four Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154371. doi: 10.1210.
    >> Share

  200. CESAREO R, Manfrini S, Pasqualini V, Ambrogi C, et al
    Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study).
    J Clin Endocrinol Metab. 2021 Feb 20. pii: 6145113. doi: 10.1210.
    >> Share

  201. ALEXANDER EK
    From the Tip to the Iceberg below - Evolving our Molecular Understanding of Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 Feb 16. pii: 6137555. doi: 10.1210.
    >> Share

  202. CHEN D, Tan Y, Li Z, Li W, et al
    Organoid cultures derived from patients with papillary thyroid cancer.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125726. doi: 10.1210.
    >> Share

    January 2021
  203. PANAGIOTOU G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al
    Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans.
    J Clin Endocrinol Metab. 2021 Jan 25. pii: 6119546. doi: 10.1210.
    >> Share

  204. DUTTA S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, et al
    Plasma cell free DNA to differentiate malignant from benign thyroid nodules.
    J Clin Endocrinol Metab. 2021 Jan 21. pii: 6105060. doi: 10.1210.
    >> Share

  205. CHONG AS, Nikiforov YE, Condello V, Wald AI, et al
    Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2021 Jan 18. pii: 6103949. doi: 10.1210.
    >> Share

  206. ZHANG L, Ren Z, Su Z, Liu Y, et al
    Novel recurrent altered genes in Chinese patients with anaplastic thyroid cancer.
    J Clin Endocrinol Metab. 2021 Jan 11. pii: 6082745. doi: 10.1210.
    >> Share

  207. MURPHY CF, Stratford N, Docherty NG, Moran B, et al
    A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
    J Clin Endocrinol Metab. 2021;106:e204-e216.
    >> Share

    December 2020
  208. GRANI G, Lamartina L, AlfO M, Ramundo V, et al
    Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk.
    J Clin Endocrinol Metab. 2020 Dec 30. pii: 6055578. doi: 10.1210.
    >> Share

  209. PITT SC, Yang N, Saucke MC, Marka N, et al
    Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
    J Clin Endocrinol Metab. 2020 Dec 29. pii: 6054975. doi: 10.1210.
    >> Share

  210. ZHU CY, Donangelo I, Gupta D, Nguyen DT, et al
    Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
    J Clin Endocrinol Metab. 2020 Dec 2. pii: 6015927. doi: 10.1210.
    >> Share

    November 2020
  211. MOON JH, Ryu CH, Cho SW, Choi JY, et al
    Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma.
    J Clin Endocrinol Metab. 2020 Nov 28. pii: 6009064. doi: 10.1210.
    >> Share

  212. CAPEZZONE M, Sagnella A, Pilli T, Maino F, et al
    Role of Age at Diagnosis in Defining Potential Familial Non-Medullary Thyroid Cancer in Kindreds with Only Two Affected Members.
    J Clin Endocrinol Metab. 2020 Nov 11. pii: 5974121. doi: 10.1210.
    >> Share

    October 2020
  213. WASSNER AJ
    Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy.
    J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943497. doi: 10.1210.
    >> Share

  214. BROOME DT, Naples R, Bailey R, Tekin Z, et al
    Use of Preoperative Imaging in Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2020 Oct 29. pii: 5942949. doi: 10.1210.
    >> Share

  215. YANG S, Jin C, Xu X
    Letter to the Editor from Shijie Yang et al: US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study.
    J Clin Endocrinol Metab. 2020 Oct 22. pii: 5936021. doi: 10.1210.
    >> Share

    September 2020
  216. SHI X, Li CW, Tan LC, Wen SS, et al
    Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3 and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    J Clin Endocrinol Metab. 2020 Sep 30. pii: 5916419. doi: 10.1210.
    >> Share

  217. RINGEL MD
    New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
    J Clin Endocrinol Metab. 2020 Sep 25. pii: 5911817. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016